Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

A novel FLI1 exonic circular RNA promotes metastasis in breast cancer by coordinately regulating TET1 and DNMT1.

Chen N, Zhao G, Yan X, Lv Z, Yin H, Zhang S, Song W, Li X, Li L, Du Z, Jia L, Zhou L, Li W, Hoffman AR, Hu JF, Cui J.

Genome Biol. 2018 Dec 11;19(1):218. doi: 10.1186/s13059-018-1594-y.

2.

Friend leukemia virus integration 1 activates the Rho GTPase pathway and is associated with metastasis in breast cancer.

Song W, Li W, Li L, Zhang S, Yan X, Wen X, Zhang X, Tian H, Li A, Hu JF, Cui J.

Oncotarget. 2015 Sep 15;6(27):23764-75.

3.

FLI1 Exonic Circular RNAs as a Novel Oncogenic Driver to Promote Tumor Metastasis in Small Cell Lung Cancer.

Li L, Li W, Chen N, Zhao H, Xu G, Zhao Y, Pan X, Zhang X, Zhou L, Yu D, Li A, Hu JF, Cui J.

Clin Cancer Res. 2019 Feb 15;25(4):1302-1317. doi: 10.1158/1078-0432.CCR-18-1447. Epub 2018 Nov 14.

PMID:
30429198
4.

3,6-Dihydroxyflavone regulates microRNA-34a through DNA methylation.

Peng X, Chang H, Chen J, Zhang Q, Yu X, Mi M.

BMC Cancer. 2017 Sep 5;17(1):619. doi: 10.1186/s12885-017-3638-1.

5.

FLI1 expression is correlated with breast cancer cellular growth, migration, and invasion and altered gene expression.

Scheiber MN, Watson PM, Rumboldt T, Stanley C, Wilson RC, Findlay VJ, Anderson PE, Watson DK.

Neoplasia. 2014 Oct 23;16(10):801-13. doi: 10.1016/j.neo.2014.08.007. eCollection 2014 Oct.

6.

SLFN11 Is a Transcriptional Target of EWS-FLI1 and a Determinant of Drug Response in Ewing Sarcoma.

Tang SW, Bilke S, Cao L, Murai J, Sousa FG, Yamade M, Rajapakse V, Varma S, Helman LJ, Khan J, Meltzer PS, Pommier Y.

Clin Cancer Res. 2015 Sep 15;21(18):4184-93. doi: 10.1158/1078-0432.CCR-14-2112. Epub 2015 Mar 16.

7.

Friend leukemia virus integration 1 promotes tumorigenesis of small cell lung cancer cells by activating the miR-17-92 pathway.

Li L, Song W, Yan X, Li A, Zhang X, Li W, Wen X, Zhou L, Yu D, Hu JF, Cui J.

Oncotarget. 2017 Jun 27;8(26):41975-41987. doi: 10.18632/oncotarget.16715.

8.

Oncogenic EGFR Represses the TET1 DNA Demethylase to Induce Silencing of Tumor Suppressors in Cancer Cells.

Forloni M, Gupta R, Nagarajan A, Sun LS, Dong Y, Pirazzoli V, Toki M, Wurtz A, Melnick MA, Kobayashi S, Homer RJ, Rimm DL, Gettinger SJ, Politi K, Dogra SK, Wajapeyee N.

Cell Rep. 2016 Jul 12;16(2):457-471. doi: 10.1016/j.celrep.2016.05.087. Epub 2016 Jun 23.

9.

HMGA2/TET1/HOXA9 signaling pathway regulates breast cancer growth and metastasis.

Sun M, Song CX, Huang H, Frankenberger CA, Sankarasharma D, Gomes S, Chen P, Chen J, Chada KK, He C, Rosner MR.

Proc Natl Acad Sci U S A. 2013 Jun 11;110(24):9920-5. doi: 10.1073/pnas.1305172110. Epub 2013 May 28.

10.
11.

DNA-methyltransferase1 (DNMT1) binding to CpG rich GABAergic and BDNF promoters is increased in the brain of schizophrenia and bipolar disorder patients.

Dong E, Ruzicka WB, Grayson DR, Guidotti A.

Schizophr Res. 2015 Sep;167(1-3):35-41. doi: 10.1016/j.schres.2014.10.030. Epub 2014 Dec 2.

12.

Fli1 and Ets1 have distinct roles in connective tissue growth factor/CCN2 gene regulation and induction of the profibrotic gene program.

Nakerakanti SS, Kapanadze B, Yamasaki M, Markiewicz M, Trojanowska M.

J Biol Chem. 2006 Sep 1;281(35):25259-69. Epub 2006 Jul 6.

13.

Homocysteine suppresses the expression of the collagen cross-linker lysyl oxidase involving IL-6, Fli1, and epigenetic DNA methylation.

Thaler R, Agsten M, Spitzer S, Paschalis EP, Karlic H, Klaushofer K, Varga F.

J Biol Chem. 2011 Feb 18;286(7):5578-88. doi: 10.1074/jbc.M110.166181. Epub 2010 Dec 9.

14.

A novel isoform of TET1 that lacks a CXXC domain is overexpressed in cancer.

Good CR, Madzo J, Patel B, Maegawa S, Engel N, Jelinek J, Issa JJ.

Nucleic Acids Res. 2017 Aug 21;45(14):8269-8281. doi: 10.1093/nar/gkx435.

15.

TET1 inhibits gastric cancer growth and metastasis by PTEN demethylation and re-expression.

Pei YF, Tao R, Li JF, Su LP, Yu BQ, Wu XY, Yan M, Gu QL, Zhu ZG, Liu BY.

Oncotarget. 2016 May 24;7(21):31322-35. doi: 10.18632/oncotarget.8900.

16.

Decrease of 5hmC in gastric cancers is associated with TET1 silencing due to with DNA methylation and bivalent histone marks at TET1 CpG island 3'-shore.

Park JL, Kim HJ, Seo EH, Kwon OH, Lim B, Kim M, Kim SY, Song KS, Kang GH, Kim HJ, Choi BY, Kim YS.

Oncotarget. 2015 Nov 10;6(35):37647-62. doi: 10.18632/oncotarget.6069.

17.

TET1 suppresses cancer invasion by activating the tissue inhibitors of metalloproteinases.

Hsu CH, Peng KL, Kang ML, Chen YR, Yang YC, Tsai CH, Chu CS, Jeng YM, Chen YT, Lin FM, Huang HD, Lu YY, Teng YC, Lin ST, Lin RK, Tang FM, Lee SB, Hsu HM, Yu JC, Hsiao PW, Juan LJ.

Cell Rep. 2012 Sep 27;2(3):568-79. doi: 10.1016/j.celrep.2012.08.030. Epub 2012 Sep 20.

19.

Hinokitiol induces DNA demethylation via DNMT1 and UHRF1 inhibition in colon cancer cells.

Seo JS, Choi YH, Moon JW, Kim HS, Park SH.

BMC Cell Biol. 2017 Feb 27;18(1):14. doi: 10.1186/s12860-017-0130-3.

20.

ERĪ± propelled aberrant global DNA hypermethylation by activating the DNMT1 gene to enhance anticancer drug resistance in human breast cancer cells.

Si X, Liu Y, Lv J, Ding H, Zhang XA, Shao L, Yang N, Cheng H, Sun L, Zhu D, Yang Y, Li A, Han X, Sun Y.

Oncotarget. 2016 Apr 12;7(15):20966-80. doi: 10.18632/oncotarget.8038.

Supplemental Content

Support Center